Page last updated: 2024-10-24

celecoxib and Lymphoma, Non-Hodgkin

celecoxib has been researched along with Lymphoma, Non-Hodgkin in 3 studies

Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
El Bary, NA1
Hashem, T1
Metwally, H1
Ghany, AA1
El Mageed, HA1
Buckstein, R1
Kerbel, RS1
Shaked, Y1
Nayar, R1
Foden, C1
Turner, R1
Lee, CR1
Taylor, D1
Zhang, L1
Man, S1
Baruchel, S1
Stempak, D1
Bertolini, F1
Crump, M1
Wang, W1
Kardosh, A1
Su, YS1
Schonthal, AH1
Chen, TC1

Trials

2 trials available for celecoxib and Lymphoma, Non-Hodgkin

ArticleYear
A phase II study of high-dose celecoxib and metronomic 'low-dose' cyclophosphamide and methotrexate in patients with relapsed and refractory lymphoma.
    Hematology/oncology and stem cell therapy, 2010, Volume: 3, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cyclooxygenase 2 Inhibitors; Cyclophospha

2010
High-Dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and refractory aggressive histology non-Hodgkin's lymphoma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Sep-01, Volume: 12, Issue:17

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Celecoxib; Cyclophosphamide; Disease Progressi

2006

Other Studies

1 other study available for celecoxib and Lymphoma, Non-Hodgkin

ArticleYear
Efficacy of celecoxib in the treatment of CNS lymphomas: an in vivo model.
    Neurosurgical focus, 2006, Nov-15, Volume: 21, Issue:5

    Topics: Animal Feed; Animals; Apoptosis; Burkitt Lymphoma; Celecoxib; Cell Line, Tumor; Central Nervous Syst

2006